Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence of Clostridium Difficile Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableStudy completedNCT04317963
What this trial is testing

Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
University of Illinois at Chicago 180
Not applicableStudy completedNCT05826418
What this trial is testing

Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation

Who this might be right for
Recurrent Clostridium Difficile InfectionFecal Microbiota Transplant
University of Minnesota 12
Large-scale testing (Phase 3)Study completedNCT03183141
What this trial is testing

ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Seres Therapeutics, Inc. 263
Large-scale testing (Phase 3)Study completedNCT03931941
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

Who this might be right for
Clostridium Difficile InfectionInfectionCommunicable Diseases
Rebiotix Inc. 793
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Not applicableStudy completedNCT03834038
What this trial is testing

Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile Infection
Vancouver Island Health Authority 158
Not applicableWithdrawnNCT04679324
What this trial is testing

The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Mayo Clinic
Large-scale testing (Phase 3)Study completedNCT05201079
What this trial is testing

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Who this might be right for
Recurrent Clostridium Difficile InfectionPrimary Clostridium Difficile Infection
Mikrobiomik Healthcare Company S.L. 93
Early research (Phase 1)Study completedNCT05911997
What this trial is testing

MTC Versus FMT in for RCDI

Who this might be right for
Clostridiodies Difficile Infections
Icahn School of Medicine at Mount Sinai 38
Not applicableEnded earlyNCT05526807
What this trial is testing

Ursodeoxycholic Acid in C. Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Nottingham University Hospitals NHS Trust 6
Not applicableUnknownNCT04012788
What this trial is testing

CDI Synbiotic Study

Who this might be right for
Clostridium Difficile Infection
Hvidovre University Hospital 50
Early research (Phase 1)Looking for participantsNCT06370884
What this trial is testing

Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection

Who this might be right for
Recurrent Clostridioides Difficile InfectionColonic Surgery
University of Minnesota 40
Large-scale testing (Phase 3)Temporarily pausedNCT01202630
What this trial is testing

BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile Infection
Bio-K Plus International Inc. 140
Not applicableApproved For MarketingNCT02437500
What this trial is testing

Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)

Who this might be right for
Clostridioides Difficile Infection
Seres Therapeutics, Inc.